Efficacy and safety of once-daily alfuzosin in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a randomized, placebo-controlled trial 1

Author： Roehrborn C.G.   for the ALFUS STUDY GROUP  

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.58, Iss.6, 2001-12, pp. : 953-959

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neoadjuvant and adjuvant alpha-blockade improves early results of high-energy transurethral microwave thermotherapy for lower urinary tract symptoms of benign prostatic hyperplasia: a randomized, prospective clinical trial - placebo-controlled, double-blind extension of phase III trial

By Djavan B.   Shariat S.   Fakhari M.   Ghawidel K.   Seitz C.   Partin A.W.   Roehrborn C.G.   Marberger M.  

Urology, Vol. 53, Iss. 2, 1999-02 ,pp. : 251-259

Elsevier

Access to resources Recommend Favorite

A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia

By Elhilali M.M.   Ramsey E.W.   Barkin J.   Casey R.W.   Boake R.C.   Beland G.   Fradet Y.   Trachtenberg J.   Orovan W.L.   Schick E.   Klotz L.H.  

Urology, Vol. 47, Iss. 3, 1996-03 ,pp. : 335-342

Elsevier

Access to resources Recommend Favorite

Long-Term Safety and Efficacy of a Once-Daily Formulation of Alfuzosin 10 mg in Patients with Symptomatic Benign Prostatic Hyperplasia: Open-Label Extension Study

By van Kerrebroeck P.   Jardin A.   van Cangh P.   Laval K.U.   The ALFORTI Study Group  

European Urology, Vol. 41, Iss. 1, 2002-01 ,pp. : 54-61

Elsevier

Access to resources Recommend Favorite

Naftopidil and propiverine hydrochloride for treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia and concomitant overactive bladder: A prospective randomized controlled study

By Yokoyama Teruhiko   Uematsu Katsutoshi   Watanabe Toyohiko   Sasaki Katsumi   Kumon Hiromi   Nagai Atsushi  

Scandinavian Journal of Urology and Nephrology, Vol. 43, Iss. 4, 2009-09 ,pp. : 307-314

Informa Healthcare

Access to resources Recommend Favorite

Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms 1

By Gerber G.S.   Kuznetsov D.   Johnson B.C.   Burstein J.D.  

Urology, Vol. 58, Iss. 6, 2001-12 ,pp. : 960-963

Elsevier

Access to resources Recommend Favorite